Stay updated on Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new Locations section has been added with Texas listed as a site. The HHS Vulnerability Disclosure and Texas Locations entries were removed, and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:50:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision tag in the page footer updated from v3.2.0 to v3.3.2, indicating a platform revision. No changes observed in study details, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:01:03.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The government funding/operating status notice has been removed. This does not change the study details, eligibility criteria, or other essential information presented on the page.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:46.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    No significant content changes detected; the page layout and core sections appear the same, with only minor cosmetic spacing and styling tweaks. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:07:02.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T05:27:10.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Core terminology updated from 'Clear cell renal carcinoma' to 'Clear cell carcinoma of kidney' and the document/page version updated to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-29T03:06:34.000Z thumbnail image

Stay in the know with updates to Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib+Nivolumab in Clear Cell Renal Cell Carcinoma Clinical Trial page.